Behavioral effects of carbamazepine after single and repeated administration in emotionally labile subjects. 1983

W Janke, and K J Ehrhardt, and U Münch

The sample investigated consisted of two groups of emotionally labile healthy male subjects who were given either 100 mg/day of the antiepileptic drug carbamazepine (n = 16) or placebo (n = 16) for 8 days. Subjects were selected on the basis of their scores in the neuroticism scale of the Freiburg Personality Inventory (FPI-A: N score greater than or equal to 6). By means of an extensive test battery (ratings of emotional state, emotional reactivity tests, performance tests, physiological parameters) at day 1 and day 8 of ingestion the psychotropic effects of carbamazepine were evaluated as well as the differences in effects after single and repeated administration. Behavioral effects could be demonstrated for carbamazepine after single administration, but the differences found were rather small and limited to four parameters. After several days of administration carbamazepine revealed clear effects on psychological parameters. It is concluded that a drug like carbamazepine needs more than a single administration to be effective in psychological tests, in contrast to tranquilizing, sedating, neuroleptic and stimulating drugs. Carbamazepine has this characteristic common with antidepressant drugs. The experiment demonstrated that carbamazepine is a drug which under the chosen dose level conditions has a positive influence on subjective emotional states, e.g. reduction of deactivation and emotional tension (anxiousness).

UI MeSH Term Description Entries
D008297 Male Males
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000342 Affective Symptoms Mood or emotional responses dissonant with or inappropriate to the behavior and/or stimulus. Alexithymia,Emotional Disturbances,Affective Symptom,Alexithymias,Disturbance, Emotional,Disturbances, Emotional,Emotional Disturbance,Symptom, Affective,Symptoms, Affective
D001519 Behavior The observable response of a man or animal to a situation. Acceptance Process,Acceptance Processes,Behaviors,Process, Acceptance,Processes, Acceptance
D013647 Task Performance and Analysis The detailed examination of observable activity or behavior associated with the execution or completion of a required function or unit of work. Critical Incident Technique,Critical Incident Technic,Task Performance,Task Performance, Analysis,Critical Incident Technics,Critical Incident Techniques,Incident Technic, Critical,Incident Technics, Critical,Incident Technique, Critical,Incident Techniques, Critical,Performance, Analysis Task,Performance, Task,Performances, Analysis Task,Performances, Task,Task Performances,Task Performances, Analysis,Technic, Critical Incident,Technics, Critical Incident,Technique, Critical Incident,Techniques, Critical Incident

Related Publications

W Janke, and K J Ehrhardt, and U Münch
September 1996, American journal of therapeutics,
W Janke, and K J Ehrhardt, and U Münch
May 1990, British journal of clinical pharmacology,
W Janke, and K J Ehrhardt, and U Münch
November 2005, Environmental toxicology and pharmacology,
W Janke, and K J Ehrhardt, and U Münch
December 1976, Journal of pharmacokinetics and biopharmaceutics,
W Janke, and K J Ehrhardt, and U Münch
December 1992, The Tokai journal of experimental and clinical medicine,
W Janke, and K J Ehrhardt, and U Münch
June 1992, Journal of psychiatry & neuroscience : JPN,
W Janke, and K J Ehrhardt, and U Münch
May 1982, European journal of pharmacology,
Copied contents to your clipboard!